165 related articles for article (PubMed ID: 15716243)
41. [The clinical and laboratory characteristics of mature (postthymic) T-cell malignant neoplasms].
Matutes E; Catovsky D
Gematol Transfuziol; 1993 May; 38(5):3-6. PubMed ID: 8034169
[No Abstract] [Full Text] [Related]
42. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract][Full Text] [Related]
43. Adult T-cell lymphoma/leukemia with angioimmunoblastic T-cell lymphomalike features: Report of 11 cases.
Karube K; Suzumiya J; Okamoto M; Takeshita M; Maeda K; Sakaguchi M; Inada T; Tsushima H; Kikuchi M; Ohshima K
Am J Surg Pathol; 2007 Feb; 31(2):216-23. PubMed ID: 17255766
[TBL] [Abstract][Full Text] [Related]
44. Leukemia cutis (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases.
Walther BS; Gibbons G; Chan EF; Ziselman E; Rothfleisch JE; Willard RJ; Baldassano MF
Am J Dermatopathol; 2009 Apr; 31(2):162-5. PubMed ID: 19318802
[TBL] [Abstract][Full Text] [Related]
45. Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: case report and review of the literature.
Karsai S; Hou JS; Telang G; Kantor GR; Nowell PC; Vonderheid EC
Dermatology; 2008; 216(1):68-75. PubMed ID: 18032903
[TBL] [Abstract][Full Text] [Related]
46. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
[TBL] [Abstract][Full Text] [Related]
47. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
[TBL] [Abstract][Full Text] [Related]
48. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
49. Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia/lymphoma, and Sézary syndrome.
Foucar K
Am J Clin Pathol; 2007 Apr; 127(4):496-510. PubMed ID: 17369126
[TBL] [Abstract][Full Text] [Related]
50. Extramedullary hand mirror cells in pathologic conditions of lymphoid tissue.
Zaharopoulos P; Wong JY; Wen JW
Acta Cytol; 1990; 34(6):868-74. PubMed ID: 2256422
[TBL] [Abstract][Full Text] [Related]
51. Prolymphocytic leukemia with suppressor T-cell phenotype: report of two cases.
Jehn U; Grunewald R; Göldel N; Meissner H; Greither L; Thiel E; Müller D
Anticancer Res; 1989; 9(1):115-8. PubMed ID: 2523211
[TBL] [Abstract][Full Text] [Related]
52. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
53. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
Bahler DW; Hartung L; Hill S; Bowen GM; Vonderheid EC
Cytometry B Clin Cytom; 2008 May; 74(3):156-62. PubMed ID: 18061949
[TBL] [Abstract][Full Text] [Related]
54. [Cutaneous erythematous rash as first manifestation of T-cell prolymphocytic lymphatic leukemia].
Beltrán Fernández L; di Martino Ortiz B; Gil Herrera J; López-Herce JA; de Portugal Alvarez J; Menárguez Palanca J
An Med Interna; 2002 Mar; 19(3):126-9. PubMed ID: 12012759
[TBL] [Abstract][Full Text] [Related]
55. Neural cell adhesion molecule expression: no correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck.
Solares CA; Brown I; Boyle GM; Parsons PG; Panizza B
Head Neck; 2009 Jun; 31(6):802-6. PubMed ID: 19283849
[TBL] [Abstract][Full Text] [Related]
56. [Leukemic meningitis in B-cell prolymphocytic leukemia].
Takahashi T; Kazama Y; Ishii S; Shimizu H; Yoshimoto M; Tsujisaki M; Imai K
Rinsho Ketsueki; 2002 Jul; 43(7):578-82. PubMed ID: 12229129
[TBL] [Abstract][Full Text] [Related]
57. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
Okamura K; Ikeda T; Shimakura Y; Yoshiba F; Kishi K; Ando K; Hotta T
Rinsho Ketsueki; 2005 Jul; 46(7):527-31. PubMed ID: 16440747
[TBL] [Abstract][Full Text] [Related]
58. Are activation markers (CD25, CD38 and CD103) predictive of sensitivity to purine analogues in patients with T-cell prolymphocytic leukemia and other lymphoproliferative disorders?
Delgado J; Bustos JG; Jimenez MC; Quevedo E; Hernandez-Navarro F
Leuk Lymphoma; 2002 Dec; 43(12):2331-4. PubMed ID: 12613520
[TBL] [Abstract][Full Text] [Related]
59. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
[TBL] [Abstract][Full Text] [Related]
60. Small cell variant of T-cell prolymphocytic leukemia exhibiting suppressor phenotype.
Thorat KB; Gujral S; Kumar A; Nair CN
Leuk Lymphoma; 2006 Aug; 47(8):1711-3. PubMed ID: 16966296
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
